Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News |
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
(TBI) Research
Technology Transfer
Office
NINDS is part of the
National Institutes of
Health
The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the Juvenile Diabetes Research Foundation International request applications for research on the effects of hypoglycemia on the function of neuronal and glial cells of the developing and mature central nervous system.* The purposes of this request for applications (RFA) are to solicit basic studies to define the effect of varying glycemic levels on cerebral metabolism, transport of glucose across the blood-brain barrier, and astrocytic regulation of substrates for neuronal metabolism, and to determine pathological consequences of acute and recurrent hypoglycemic insult on cells of the central nervous system. Examples of potential areas of research include studies to: evaluate the role of glial-derived alternative fuels in the maintenance of neuronal and glial function; examine cellular physiological alterations in response to hypoglycemia; determine the role of astrocytic glycogen in maintaining neuronal function and survival during hypoglycemia; elucidate the effects of hypoglycemia on mechanisms regulating astrocytic uptake of glutamate; assess the extent and mechanism of CNS damage during acute or recurrent hypoglycemia, and to determine whether sensitivity to hypoglycemia varies with age; and determine whether there is a therapeutic window during which hypoglycemia-induced CNS damage can be ameliorated or reversed. Also encouraged are studies on the relationship between the astrocyte pentose phosphate pathway, oxidative stress, and brain injury during glucose deprivation; interactions between astrocytes and other cell types such as oligodendrocytes and their relationship to brain injury during hypoglycemia; and potential agents that could be used to mitigate hypoglycemia-induced neuronal damage. APPLICATION RECEIPT DATE: March 15, 2002. For more information, potential applicants should contact Dr. Toby Behar, Program Director, Neural Environment Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2114A, Bethesda, MD 20892; telephone: (301) 496-1431; fax: (301) 480-2424; e-mail: tb72z@nih.gov.
*For a more detailed description of this RFA, please visit the NIH web site at: http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-02-008.html.
This content has been adapted from the original NINDS Notes publication. For the most up-to-date funding information, please visit the Funding Opportunities section of the NINDS web site. For the most recent information on NINDS studies, please visit the NINDS Patient Recruitment web site.